Glenmede Trust Co. NA Sells 3,698 Shares of Humana Inc. $HUM

Glenmede Trust Co. NA reduced its stake in Humana Inc. (NYSE:HUM) by 15.0% during the first quarter, according to its most recent filing with the SEC. The fund owned 20,966 shares of the insurance provider’s stock after selling 3,698 shares during the quarter. Glenmede Trust Co. NA’s holdings in Humana were worth $3,635,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in HUM. Edgestream Partners L.P. purchased a new stake in Humana during the first quarter worth about $5,888,000. Kentucky Retirement Systems boosted its stake in Humana by 69.8% in the first quarter. Kentucky Retirement Systems now owns 12,872 shares of the insurance provider’s stock valued at $2,232,000 after acquiring an additional 5,293 shares during the last quarter. Janus Henderson Group PLC boosted its stake in Humana by 8.8% in the first quarter. Janus Henderson Group PLC now owns 219,065 shares of the insurance provider’s stock valued at $37,983,000 after acquiring an additional 17,629 shares during the last quarter. Centaurus Financial Inc. boosted its stake in Humana by 126.7% in the first quarter. Centaurus Financial Inc. now owns 3,400 shares of the insurance provider’s stock valued at $590,000 after acquiring an additional 1,900 shares during the last quarter. Finally, South Dakota Investment Council grew its position in shares of Humana by 42.0% during the 1st quarter. South Dakota Investment Council now owns 229,090 shares of the insurance provider’s stock valued at $39,722,000 after acquiring an additional 67,707 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE HUM opened at $362.32 on Wednesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The stock has a market cap of $43.51 billion, a PE ratio of 34.28, a price-to-earnings-growth ratio of 2.14 and a beta of 0.72. The stock has a fifty day moving average of $373.31 and a 200-day moving average of $269.64.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same period in the prior year, the firm posted $6.27 earnings per share. Equities research analysts anticipate that Humana Inc. will post 9.08 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on HUM. Wolfe Research upgraded shares of Humana from a “peer perform” rating to an “outperform” rating in a research note on Thursday, July 30th. Oppenheimer reiterated an “outperform” rating and issued a $405.00 price objective on shares of Humana in a research note on Thursday, July 30th. Guggenheim raised their target price on Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. UBS Group started coverage on Humana in a research note on Thursday, July 30th. They issued a “buy” rating on the stock. Finally, Raymond James Financial downgraded Humana from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, thirteen have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $391.87.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.